Trappetti Verdiana, Fazzari Jennifer, Fernandez-Palomo Cristian, Smyth Lloyd, Potez Marine, Shintani Nahoko, de Breuyn Dietler Bettina, Martin Olga A, Djonov Valentin
Institute of Anatomy, University of Bern, Baltzerstarsse 2, 3012 Bern, Switzerland.
Department of Obstetrics and Gynaecology, Royal Women's Hospital, University of Melbourne, Melbourne, VIC 3052, Australia.
Biomedicines. 2022 Mar 22;10(4):735. doi: 10.3390/biomedicines10040735.
Radiation therapy (RT) is a vital component of multimodal cancer treatment, and its immunomodulatory effects are a major focus of current therapeutic strategies. Macrophages are some of the first cells recruited to sites of radiation-induced injury where they can aid in tissue repair, propagate radiation-induced fibrogenesis and influence tumour dynamics. Microbeam radiation therapy (MRT) is a unique, spatially fractionated radiation modality that has demonstrated exceptional tumour control and reduction in normal tissue toxicity, including fibrosis. We conducted a morphological analysis of MRT-irradiated normal liver, lung and skin tissues as well as lung and melanoma tumours. MRT induced distinct patterns of DNA damage, reflecting the geometry of the microbeam array. Macrophages infiltrated these regions of peak dose deposition at variable timepoints post-irradiation depending on the tissue type. In normal liver and lung tissue, macrophages clearly demarcated the beam path by 48 h and 7 days post-irradiation, respectively. This was not reflected, however, in normal skin tissue, despite clear DNA damage marking the beam path. Persistent DNA damage was observed in MRT-irradiated lung carcinoma, with an accompanying geometry-specific influx of mixed M1/M2-like macrophage populations. These data indicate the unique potential of MRT as a tool to induce a remarkable accumulation of macrophages in an organ/tissue-specific manner. Further characterization of these macrophage populations is warranted to identify their organ-specific roles in normal tissue sparing and anti-tumour responses.
放射治疗(RT)是多模式癌症治疗的重要组成部分,其免疫调节作用是当前治疗策略的主要焦点。巨噬细胞是最早被招募到辐射诱导损伤部位的细胞之一,它们可以帮助组织修复、促进辐射诱导的纤维化并影响肿瘤动态。微束放射治疗(MRT)是一种独特的、空间分割的放射模式,已证明在肿瘤控制和降低包括纤维化在内的正常组织毒性方面表现出色。我们对接受MRT照射的正常肝脏、肺和皮肤组织以及肺癌和黑色素瘤肿瘤进行了形态学分析。MRT诱导了独特的DNA损伤模式,反映了微束阵列的几何形状。巨噬细胞在照射后的不同时间点浸润到这些高剂量沉积区域,这取决于组织类型。在正常肝脏和肺组织中,巨噬细胞分别在照射后48小时和7天清楚地勾勒出束流路径。然而,在正常皮肤组织中并未观察到这种情况,尽管束流路径有明显的DNA损伤标记。在接受MRT照射的肺癌中观察到持续的DNA损伤,同时伴有混合的M1/M2样巨噬细胞群体的几何形状特异性流入。这些数据表明MRT作为一种工具具有独特的潜力,能够以器官/组织特异性方式诱导巨噬细胞显著聚集。有必要对这些巨噬细胞群体进行进一步表征,以确定它们在正常组织保护和抗肿瘤反应中的器官特异性作用。